1. Home
  2. SBFM vs APDN Comparison

SBFM vs APDN Comparison

Compare SBFM & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • APDN
  • Stock Information
  • Founded
  • SBFM 2006
  • APDN 1983
  • Country
  • SBFM United States
  • APDN United States
  • Employees
  • SBFM N/A
  • APDN N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • APDN Other Consumer Services
  • Sector
  • SBFM Health Care
  • APDN Consumer Discretionary
  • Exchange
  • SBFM Nasdaq
  • APDN Nasdaq
  • Market Cap
  • SBFM 4.6M
  • APDN 4.2M
  • IPO Year
  • SBFM N/A
  • APDN N/A
  • Fundamental
  • Price
  • SBFM $1.51
  • APDN $5.37
  • Analyst Decision
  • SBFM Strong Buy
  • APDN Strong Buy
  • Analyst Count
  • SBFM 1
  • APDN 1
  • Target Price
  • SBFM $15.00
  • APDN $1,125.00
  • AVG Volume (30 Days)
  • SBFM 104.9K
  • APDN 129.8K
  • Earning Date
  • SBFM 05-15-2025
  • APDN 05-15-2025
  • Dividend Yield
  • SBFM N/A
  • APDN N/A
  • EPS Growth
  • SBFM N/A
  • APDN N/A
  • EPS
  • SBFM N/A
  • APDN N/A
  • Revenue
  • SBFM $36,234,578.00
  • APDN $3,790,616.00
  • Revenue This Year
  • SBFM $192.48
  • APDN $57.08
  • Revenue Next Year
  • SBFM N/A
  • APDN $40.00
  • P/E Ratio
  • SBFM N/A
  • APDN N/A
  • Revenue Growth
  • SBFM 35.51
  • APDN N/A
  • 52 Week Low
  • SBFM $1.17
  • APDN $4.37
  • 52 Week High
  • SBFM $11.39
  • APDN $2,655.00
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 54.20
  • APDN 22.45
  • Support Level
  • SBFM $1.37
  • APDN $4.96
  • Resistance Level
  • SBFM $1.56
  • APDN $6.50
  • Average True Range (ATR)
  • SBFM 0.08
  • APDN 1.06
  • MACD
  • SBFM 0.02
  • APDN 0.39
  • Stochastic Oscillator
  • SBFM 73.68
  • APDN 17.44

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About APDN Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Share on Social Networks: